Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NOC

Market Inference Reports -- NOC Stock

Large-cap Industrials company Northrop Grumman has logged a 1.3% change today on a trading volume of 305,084. The average volume for the stock is 1,155,329.

Northrop Grumman Corporation operates as an aerospace and defense technology company in the United States, the Asia/Pacific, Europe, and internationally. Based in Falls Church, United States the company has 97,000 full time employees and a market cap of $67,721,297,920. Northrop Grumman currently offers its equity investors a dividend that yields 1.3% per year.

The company is now trading -14.5% away from its average analyst target price of $549.78 per share. The 23 analysts following the stock have set target prices ranging from $463.83 to $620.0, and on average give Northrop Grumman a rating of buy.

Over the last 12 months NOC shares have declined by -2.2%, which represents a difference of -6.5% when compared to the S&P 500. The stock's 52 week high is $555.57 per share and its 52 week low is $418.6. Based on Northrop Grumman's average net margin growth of 6.4% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 41,033,000 4,174,000 10 100.0
2023 39,290,000 2,056,000 5 -61.54
2022 36,602,000 4,896,000 13 -35.0
2021 35,667,000 7,005,000 20 122.22
2020 36,799,000 3,189,000 9 28.57
2019 33,841,000 2,248,000 7
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS